Healthcare Data Collection And Labeling Market
Report ID: SQMIG35G2425
Report ID: SQMIG35G2425
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35G2425 |
Region:
Global |
Published Date: May, 2026
Pages:
157
|Tables:
207
|Figures:
80
Global Healthcare Data Collection And Labeling Market size was valued at USD 4.10 Billion in 2024 and is poised to grow from USD 5.10 Billion in 2025 to USD 29.47 Billion by 2033, growing at a CAGR of 24.5% during the forecast period (2026-2033).
Rapid AI and machine learning adoption within the provision of clinical care is the driving factor of the healthcare data collection and labelling market trends. Due to this rapid adoption, there is a higher demand for annotated dataset collections with quality assurance. The product segment will provide model development to collect, process, label and generate datasets containing medically necessary data (e.g., imaging, electronic health records, pathology slides and sensor data from wearable devices). Accurate labels enhance diagnostic accuracy; provide therapy tailored specifically for a patient; and enhance the quality of the healthcare delivery process. Achievements of regulatory bodies over time have transformed the healthcare industry from manual abstraction to standards due to the implementation of the HITECH act and the interoperability standards of HL7 FHIR. For example, radiological datasets annotated for use in the detection of cancer can be used as a justification of current practices and support future practice methodology. The growth engine for the global health data collection and labelling marketplace will be improving timely and accurate data through the digitisation of our healthcare systems (e.g., hospital digitisation, telemedicine and wearable devices) that will create a demand for datasets that will be labelled and used with ai based solutions.
Consequently, there is an increase in the number of vendors supplying labelling services for images, genomic profiles, and sensor outputs while the pressure of the regulatory bodies overseeing the creation of validated, explainable models is creating pressure for more rigorous labelling protocols. For example, annotated CT scans will facilitate the expedient triage of stroke patients; labelled electronic health record phenotypes will allow for more rapid patient recruitment for clinical trials; and labelled electronic recordings from the ecg will facilitate remote cardiac monitoring. Additionally, with the rapid growth of data as a result of digitisation and the need for all businesses to comply with regulations, there are many opportunities within the marketplace for vendor organisations that supply speciality solutions (e.g., labelling) using an active learning approach or providing federated labelling solutions that will significantly decrease the overall expense of doing business while improving the overall quality and security of vendors "branding".
How is AI Improving Accuracy and Scalability in Healthcare Data Collection and Labeling?
AI enhances the precision and scale of healthcare data collection and labeling market growth through the automation of repetitive annotation tasks, harmonization of clinical text and image inputs, and most importantly directing the effort of experts to cases most in need of their expertise. It does this by providing three key areas of capability, automated segmentation of images; natural language processing on clinical notes; and active learning that identifies the most uncertain cases for expert review. Demand for reliable labeled datasets has made the market value of the current healthcare data collection and labeling environment constrained by limited time availability of clinicians. By reducing the manual workload of annotators and improving the consistency of labels across datasets, AI enables teams to create larger, more diverse datasets that span multiple institutions in order to accelerate model training and validation for real world evidence.
In March of 2026, Cornerstone AI expanded its relationship with Loopback Health to advance the cleaning and standardizing of laboratory data. This AI-based solution improves the speed of labeling workflows, increases consistency of data, and increases the rate at which datasets can be created which in turn supports more efficient generation of real world evidence in the healthcare data collection and labeling market.
Market snapshot - (2026-2033)
Global Market Size
USD 4.1 Billion
Largest Segment
Services
Fastest Growth
Software
Growth Rate
24.5% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global healthcare data collection and labeling market is segmented by component, data type, labeling type, technology, application, end user, deployment type and region. Based on component, the market is segmented into software and services. Based on data type, the market is segmented into medical imaging data, electronic health records (EHRs), genomic data, clinical trial data, wearable & sensor data and others. Based on labeling type, the market is segmented into image annotation, text annotation, audio annotation, video annotation and others. Based on technology, the market is segmented into AI-assisted labeling, manual labeling, automated data collection and NLP-based annotation. Based on application, the market is segmented into medical imaging analysis, clinical decision support, drug discovery, remote patient monitoring, predictive analytics and others. Based on end user, the market is segmented into healthcare providers, pharmaceutical & biotechnology companies, AI & healthtech companies, research institutes and contract research organizations (CROs). Based on deployment type, the market is segmented into cloud-based and on-premise. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
The medical imaging data segment controls the market for healthcare data collection and labeling, due to the continuing need for high-quality labeled datasets, stemming from large volumes of imaging data and the diagnostic importance of images within clinical practice. The specialized annotation requirements for imaging modalities such as radiology and pathology create entry barriers for non-specialist annotation providers; additionally, the involvement of clinicians and the regulatory scrutiny surrounding the use of images creates a level of quality that necessitates investment by annotation providers into their annotation workflows, validation processes, and tools – further establishing the medical imaging data segment's dominance.
However, electronic health records segment is rapidly expanding as growing availability of clinical notes and structured records increases demand for semantic annotation and entity extraction. Advances in NLP and interoperability requirements spur curated EHR datasets that power clinical decision support and real world evidence, unlocking new labeling services and platform opportunities.
The image annotation segment is the largest segment within the healthcare data collection and labeling market share, due to clinical workflow and regulatory validation relying on the accuracy of visual labels used in the diagnosis and treatment planning process. As a result, both the desire for pixel-level, bounding-box, and segmentation-level annotations along with the requirement for specialist annotators, extensive domain knowledge and effective quality assurance processes, create high-level provider capability and therefore high barriers to entry which further concentrate volumes and investments within large, established annotation solutions.
Meanwhile, text annotation segment is rapidly growing as clinical notes and reporting requirements increase demand for labeled text. NLP progress and appetite for structured real world evidence drive investment in scalable pipelines, workforce training, and tooling that shorten validation cycles and expand commercial applications in healthcare analytics.
To get detailed segments analysis, Request a Free Sample Report
Through a combination of established clinical infrastructure, a strong ecosystem of technology providers and alignment between research and commercial providers in North America, the region is well-positioned to remain the leader in medical technology and the life sciences. Healthcare organizations and life science companies throughout the region are focused on digitizing and assuring quality to meet the high level of demand for robust annotation and labeling services for imaging, clinical notes and biosignal data. Additionally, data privacy and governance standards imposed by regulatory agencies have created a market for compliant data handling and labeling methodologies. A deep pool of experienced annotation specialists and data scientists, the geographic concentration of venture capital with medical technology/AI-related companies, and the frequency of public/private collaborations have created a concentrated capability and innovation in this sector. These structural advantages create an environment for vendors to scale complex service offerings and jointly develop solutions with large-scale institutional customers.
Healthcare data collection and labeling market outlook in United States is shaped by a dense clinical research ecosystem and an established commercial market for AI enabled healthcare solutions. Large integrated health systems and academic medical centers supply diverse, high quality data and form strategic partnerships with labeling vendors. Demand is driven by clinical trial needs, diagnostic imaging projects, and enterprise analytics programs that require rigorous annotation standards. Strong private investment, specialized service providers, and a regulatory framework focused on data protection collectively support a vibrant market for sophisticated labeling services.
Healthcare data collection and labeling market forecast in Canada is benefiting from initiatives to centralise health data and collaboration of provincial health services with research hospitals. The focus placed on interoperability and national standards has resulted in consistent labelling practices, while bilingual data requirements have created the need for specific workflows for annotation. Pilot projects demonstrating the value of curated datasets are being made possible by public funding mechanisms and relationships with academic institutions. The market for this service is characterised by well-governed, high-quality, controlled datasets and increasing numbers of international vendors seeking reputable providers of annotated healthcare data forming partnerships.
Europe is experiencing rapid expansion as a result of coordinated national and transnational efforts to modernize healthcare data infrastructure and support innovation. Strong clinical research networks and a thriving medtech industry create steady demand for annotated datasets across imaging, genomics, and real world evidence. Regulatory frameworks that emphasize patient privacy and data protection have incentivized development of compliant labeling services and secure data sharing platforms. Cross border collaborations, standardization initiatives, and a growing pool of specialized vendors enable scalable labeling solutions. Investment from both public research bodies and private enterprises, combined with a strong base of clinical expertise and digital health adoption, positions the region for accelerated deployment of high quality labeled data for AI and analytics applications.
Healthcare data collection and labeling market penetration in Germany; the rapid digitisation of clinical environments, and the strong industrial base for medical technologies in the country. As clinical environments focus on quality, standardisation, and integration with hospital information systems, use of structured labelling services is promoted. Research intensive hospitals, together with diagnostics manufacturers, collaborate with providers of annotation services to enable the provision of advanced imaging and device related datasets. Consequently, the healthcare data collection and labeling market represents a balanced approach; combining rigorous data governance along with innovations in the clinical decision support and AI based diagnostic pipeline industries.
Healthcare data collection and labeling market regional outlook in United Kingdom is anchored by large scale national health record systems and an established culture of health data research. Integrated clinical datasets and health research hubs provide rich sources of diverse, longitudinal data for annotation. The market benefits from active collaboration between academic researchers, clinical networks, and private vendors that translate curated datasets into validated AI solutions. A strong regulatory and ethical framework for data use supports trusted partnerships and sustained demand for high quality labeling services.
Healthcare data collection and labeling market regional forecast in France, this is supported by an expanding ecosystem of new business start-up companies that are using the power of technology (through Medical Artificial Intelligence) and the development/maintenance of medical data curation/repositories. France's national health service (NHS) is currently leveraging the data that is available within their health service database/assets, as well as using data available from research institutions when creating annotated datasets. Language and regulatory factors are influencing how different organisations develop specialised workflows for labelling medical data; the level of investment into clinical research and diagnostic innovation is also fueling the increase in demand for labelling platforms.
Asia Pacific is strengthening its market position through strategic investments in digital health infrastructure, expansion of clinical research activity, and accelerated adoption of AI driven diagnostic tools. Governments and private stakeholders are prioritizing data capability building, establishing secure environments for clinical data access and incentivizing partnerships with international technology firms. Growing local expertise in medical imaging, genomics, and biosignal analysis is complemented by strong IT and cloud infrastructure that supports scalable annotation projects. Multinational and local vendors are adapting labeling workflows to regional language, clinical practice, and regulatory requirements, while talent development initiatives and academic industry collaborations are cultivating a pipeline of skilled annotation professionals. These combined efforts are elevating the region as a source of high quality labeled healthcare datasets.
Healthcare data collection and labeling market analysis in Japan for the collection and labeling of healthcare-related data uses the high-quality clinical datasets and strict standardization of their process to create a foundation for building clinical level AI systems, due to having an established medical device and diagnostics industry in Japan. The industry also benefits from working with academic institutions to create curated datasets of imaging and genomic information for use in regulatory grade AI development. There is also a cultural emphasis on precision in healthcare data management and process discipline, as well as partnerships with technology vendors to create complex workflows when processing healthcare data. Consequently, this market contains a high level of governance and an emerging relationship, between the clinical requirements and capability of annotating provided data.
Healthcare data collection and labeling industry in South Korea is supported by strong IT infrastructure, a vibrant AI research community, and rapid integration of digital health solutions within hospital networks. Close collaboration between technology firms and clinical institutions enables efficient annotation pipelines for imaging and biosignal datasets. Government programs and private sector investment enhance capabilities in data governance and tool development, while export oriented service providers position the country as a competitive hub for precise, technologically advanced labeling services.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Adoption Of Advanced Annotation Tools
Growing Demand For Diverse Data Modalities
Data Privacy and Compliance Challenges
High Annotation Cost and Complexity
Request Free Customization of this report to help us to meet your business objectives.
Increased buyer demand for privacy-compliant, independently annotated datasets, competition is becoming more intense in the global market for healthcare data collection and labelling. As a result of this demand for privacy-compliant, expert-annotated datasets, companies within this space are increasingly looking to M&A to grow their customer bases. Examples of this can be seen in Nvidia acquiring synthetic data company Gretel, strategic partnerships with customers such as Snorkel's collaboration with enterprise customers in healthcare, and rapid technical advancements such as Snorkel Flow's programmatic labelling tool and Encord's integration of foundation models into the labelling workflow.
Top Player’s Company Profile
Recent Developments in the Healthcare Data Collection And Labeling Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global healthcare data collection and labeling market is propelled by a key driver which is rapid adoption of AI and machine learning across clinical care, while a major restraint is data privacy and compliance complexities that limit cross-border sharing and increase costs. North America remains the dominating region due to advanced clinical infrastructure and strong vendor ecosystems. Medical imaging data is the dominating segment because of high volumes and regulatory demands for precise annotations. A second driver is growing demand for diverse data modalities including genomics, EHRs and wearable sensors, which expands opportunities for specialized labeling services and federated annotation models.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 4.1 Billion |
| Market size value in 2033 | USD 29.47 Billion |
| Growth Rate | 24.5% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Healthcare Data Collection And Labeling Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Healthcare Data Collection And Labeling Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Healthcare Data Collection And Labeling Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Healthcare Data Collection And Labeling Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Healthcare Data Collection And Labeling Market size was valued at USD 4.1 Billion in 2024 and is poised to grow from USD 5.1 Billion in 2025 to USD 29.47 Billion by 2033, growing at a CAGR of 24.5% during the forecast period (2026-2033).
Competition in the global healthcare data collection and labeling market is intensifying as buyers demand privacy compliant, expert annotated datasets. That pressure drives M&A, exemplified by Nvidia’s acquisition of synthetic data vendor Gretel, strategic customer partnerships such as Snorkel’s enterprise healthcare collaborations, and rapid technical innovation like Snorkel Flow’s programmatic labeling and Encord’s integration of foundation models into annotation workflows. 'TELUS Corporation', 'iMerit', 'Cogito Tech', 'Scale AI', 'Appen', 'Sama', 'CloudFactory', 'Defined.ai', 'Centaur Labs', 'Snorkel AI', 'SuperAnnotate', 'Labelbox', 'Encord', 'V7', 'Alegion', 'Mindy Support', 'Anolytics', 'Shaip', 'Turing', 'Innodata'
Advanced annotation tools streamline labeling workflows and enable more consistent, higher-quality data preparation that supports development of clinical AI and analytics solutions. Automation of repetitive tasks and built-in quality assurance reduces manual burden and helps organizations scale data operations across modalities, enhancing dataset traceability and reliability. These improvements boost stakeholder confidence and allow teams to iterate more rapidly on models, integrate labeling into ongoing development cycles, and deploy data-driven healthcare applications with reduced operational complexity and clearer governance around annotated datasets.
Federated Annotation Ecosystems: Growing demand for distributed data labeling approaches encourages hospitals, research centers, and vendors to collaborate without centralizing patient records. Platforms that enable local annotation, standardized ontologies, and secure model aggregation reduce friction in cross-institutional projects. Governance layers that define roles, provenance, and quality metrics build trust among stakeholders. The trend accelerates development of consortium tools and deployment patterns that balance clinical utility with institutional autonomy, creating new service models and partnerships around shared annotation workflows and multidisciplinary governance practices evolving.
Why does North America Dominate the Global Healthcare Data Collection And Labeling Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
